[Secondary prevention after urological tumor diseases. Focusing on the kidneys, testes, and bladder].
It is generally agreed upon that patients require a caring as well as careful medical follow-up after cancer treatment. The goal of secondary prevention is to recognize a recurrence at an early stage and to use the curative chance while the tumor mass is still small. There is evidence of a medically effective and successful follow-up for tumors of the testicle and the bladder. For quality reasons, these follow-up regimes should be adhered to for quality reasons. In other diseases, e.g., renal cell carcinoma, prospective randomized studies are missing which demonstrate the effectiveness of follow-ups. In these cases asymptomatic patients should be stratified to individualized follow-up care.
Mathers
M J
MJ
Urologische Gemeinschaftspraxis, Kooperationspraxis der Klinik für Urologie und Kinderurologie, Klinikum Wuppertal, Universität Witten/Herdecke, Fastenrathstrasse 1, 42853 Remscheid, Germany. drmathers@urologie-remscheid.de
Lazica
D A
DA
Klotz
T
T
Sommer
F
F
Roth
S
S
D000359:Aftercare; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control*; D008207:Lymphatic Metastasis / Q000175:diagnosis / Q000473:pathology; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control*; D009367:Neoplasm Staging; D012307:Risk Factors; D013736:Testicular Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000517:prevention & control*